SCPS Statement: Medtronic Field Safety Notice and National Cannula Supply Challenges

‍

1 July 2026

‍

The Society of Clinical Perfusion Scientists of GB and Ireland (SCPS) acknowledges the Medtronic Field Safety Notice issued today and recognises the potential implications this may have for perfusion services and cardiac surgery programmes across the UK and Ireland.

Over recent months, the SCPS Safety Committee has been actively monitoring, coordinating and escalating concerns relating to the national perfusion cannula supply challenges. What initially presented as isolated supply difficulties rapidly evolved into a wider patient safety and service resilience issue affecting multiple critical perfusion product lines.

Recognising the potential impact on patient care, the Society undertook a significant national leadership and coordination role, working collaboratively with NHS England, NHS Supply Chain, MHRA, NSDR, procurement colleagues, manufacturers and frontline clinical teams to develop a clearer understanding of the national picture and support continuity of care.

Through the leadership of the SCPS Safety Committee, intelligence was gathered from centres across the UK and Ireland, national stock surveys were undertaken, information validated directly with manufacturers and concerns escalated through the appropriate governance channels. Regular communications and updates were provided to members throughout this period.

Importantly, a recent multi-agency stakeholder meeting brought together NHS England, NHS Supply Chain, MHRA, manufacturers, procurement colleagues and clinical representatives to discuss current risks, mitigation strategies and longer-term resilience measures. This collaborative approach reflects the shared commitment across the system to maintaining safe cardiac surgical services.

Despite prolonged disruption, widespread patient harm has been avoided through the extraordinary efforts of perfusion teams, surgeons, anaesthetists, procurement teams, suppliers and national stakeholders, all of whom have demonstrated remarkable adaptability, professionalism and commitment to patient safety.

The current situation has highlighted the importance of:

🔹 Early escalation and transparent communication

🔹 National visibility of critical consumable stock

🔹 Diversification of supply routes and suppliers

🔹 Strong local and national governance arrangements

🔹 Collaborative working across organisational boundaries

🔹 Recognising critical consumable shortages as patient safety events rather than solely procurement issues.

The Society will continue to work closely with all stakeholders to support services, share intelligence and advocate for the development of more resilient national systems to safeguard the future delivery of cardiac surgery.

The SCPS would like to thank Rebecca Friar and the Safety Committee, Chief Perfusionists, manufacturers, NHS colleagues and all members who have contributed information, expertise and support throughout this challenging period.

Patient safety remains our absolute priority.

‍